Literature
- 2024 – GOLDIC for the management of knee osteoarthritis (10/2024)
- 2024 – Review of Goldic’s Properties, Synthesis & Biomedical Applications
- 2023 – Gold-Induced Cytokine (GOLDIC®) Therapy in the Management of Knee Osteoarthritis: An Observational Study
- 2023 – GOLD-Induced Cytokine (GOLDIC): A Game Changer Orthobiologic in Regenerative Medicine
- 2022 – Post Covid19 Syndrome Treatment using Autologous Gold-Activated Serum: A Preliminary Clinical Study
- 2022 – GOLDIC therapy in degenerative lumbar spinal stenosis: randomized, controlled trial
- 2022 – Efficacy and Safety of Regenerative Treatment in Knee Osteoarthritis Patients after COVID-19 Vaccination
- 2022 – Anti‑inflammatory effects of an Autologous Gold‑based Serum Therapy in Osteoarthritis Patients
- 2022 – RS3PE Syndrome-Orthobiological Therapy
- 2021 – Gold-based blood serum treatment promotes wound closure of corneal epithelial cell defects in primary in vitro experiments
- 2021 – Schneider et al The regeneration of damaged connective tissue: wishful thinking or reality?
- 2021 – Schneider et al Safety and efficacy of systemically administered autologous Gold-Induced Cytokines (GOLDIC®)
- 2021 – Schneider et al Intravenous gold-induced autologous serum injection therapy (Go ACT®) as a new treatment for seasonal pollen-based allergiess
- 2021 – GOLDIC® – Next Generation Regeneration
- 2021 – Feldt et al Gold-based blood serum treatment promotes wound closure of corneal epithelial cell defects in primary in vitro experiments
- 2021 – First results of Gold-induced activated serum injections (GOLDIC®) for Dupuytren disease
- 2021 – Knee Biologics
- 2020 – Schneider et al Intra-articular gold induced cytokine (GOLDIC®) injection therapy in patients with osteoarthritis of knee joint: a clinical study
- 2020 – Fuerst et al A prospective comparison of the GOLDIC® technique and corticosteroid plus hyaluronic acid injections for arthrogenic lameness in horses
- 2019 – Schneider Intra-articular Gold Induced Cytokine (GOLDIC®) Injections Therapy in Patients with Osteoarthritis of Knee Joint: A Clinical Study
- 2018 – Piktel et al Plasma Gelsolin: Indicator of Inflammation and Its Potential as a Diagnostic Tool and Therapeutic Target
- 2017 – Muscle and Tendon Injuries Springer Verlag
- 2017 – Gold-Induced Autologous Cytokine Treatment in Achilles Tendinopathy
- 2014 – Krzysztof The Autologous Gelsolin Combined with Exogenous Nucleotides enhance Chondrogenic Differentiation in Equine Adipose Derived Mesenchymal Stromal Cells – An In Vitro Research
- 2014 – Hoch – Concise Review: Optimizing Expansion of Bone Marrow Mesenchymal Stem/Stromal Cells for Clinical Applications
- 2013 – Schneider – First Results on the Outcome of Gold-induced, Autologous-conditioned Serum (GOLDIC) in the Treatment of Different Lameness-associated Equine Diseases
- 2013 – Robin Young – Goldic Orthopedics This Week 1
- 2013 – AAOS Treatment of Osteoarthritis of the Knee Guideline 1
- 2011 – Hraha Autologous conditioned serum: The comparative cytokine profiles of two commercial methods (IRAP and IRAP II) using equine blood
- 2010 – Kulakowska Gelsolin Link to Multiple Sclerosis 1
- 2010 – GuoHuaLi – Multifunctional Roles of Gelsolin in Health and Diseases
- 2010 – Giljohann Gold Nanoparticles
- 2010 – Caplan – Mesenchymal Stem Cells: The Past, the Present, the Future
- 2009 – Lee et al Plasma Gelsolin and Circulating Actin Correlate with Hemodialysis Mortality
- 2008 – Osborn Decreased Levels of the Gelsolin Plasma
- 2008 – Bucki Plasma Gelsolin: Function, Prognostic Value, and Potential Therapeutic Use
- 2006 Stuhlmeier Gold Salt Suppresses Interleukin1 induced Hyaluronan Accumulation 1
- 2002 – DiNubile et al Prognostic implications of declining plasma gelsolin levels after allogeneic stem cell transplantation
- 2000 – Chellaiah et al Gelsolin Deficiency Blocks Podosome Assembly and Produces Increased Bone Mass and Strength
- 1999 – Hui Qiao Sun – Gelsolin, a Multifunctional Actin Regulatory Protein*
- 1999 – Dahl et al Plasma Gelsolin is Reduced in Trauma Patients
- 1997 – Kuzumaki et al Inhibition of Apoptosis by the Actin-Regulatory Protein Gelsolin